Qatar Metabolic Institute, Endocrine Department, Hamad Medical Corporation, Doha, Qatar.
Department of Biostatistics, College of Health Sciences, Qatar University, Doha, Qatar.
PLoS One. 2018 Aug 3;13(8):e0201247. doi: 10.1371/journal.pone.0201247. eCollection 2018.
Diabetes first detected during pregnancy is currently divided into gestational diabetes mellitus (GDM) and diabetes mellitus (DM)- most of which are type 2 DM (T2DM). This study aims to define the prevalence and outcomes of diabetes first detected in pregnancy based on 75-gram oral glucose tolerance test (OGTT)using the recent WHO/IADPSG guidelines in a high-risk population.
This is a retrospective study that included all patients who underwent a 75 g (OGTT) between Jan 2016 and Apr 2016 and excluded patients with known pre-conception diabetes.
The overall prevalence of newly detected diabetes in pregnancy among the 2000 patients who fulfilled the inclusion/exclusion criteria was 24.0% (95% CI 22.1-25.9) of which T2DM was 2.5% (95% CI 1.9-3.3), and GDM was 21.5% (95% CI 19.7-23.3). The prevalence of newly detected diabetes in pregnancy was similar among the different ethnic groups. The T2DM group was older (mean age in years was 34 ±5.7 vs 31.7±5.7 vs 29.7 ±5.7, p<0.001); and has a higher mean BMI (32.4±6.4 kg/m2 vs 31.7±6.2 kg/m2 vs 29.7± 6.2 kg/m2, p< 0.01) than the GDM and the non-DM groups, respectively. The frequency of pre-eclampsia, pre-term delivery, Caesarean-section, macrosomia, LGA and neonatal ICU admissions were significantly higher in the T2DM group compared to GDM and non-DM groups.
Diabetes first detected in pregnancy is equally prevalent among the various ethnic groups residing in Qatar. Newly detected T2DM carries a higher risk of poor pregnancy outcomes; stressing the importance of proper classification of cases of newly detected diabetes in pregnancy.
目前,妊娠期首次诊断的糖尿病分为妊娠期糖尿病(GDM)和糖尿病(DM)-其中大多数为 2 型糖尿病(T2DM)。本研究旨在根据最近的世界卫生组织/国际妊娠合并糖尿病研究组(IADPSG)指南,在高危人群中,用 75 克口服葡萄糖耐量试验(OGTT)定义基于妊娠首次诊断的糖尿病的患病率和结局。
这是一项回顾性研究,纳入了 2000 名于 2016 年 1 月至 2016 年 4 月期间接受 75g(OGTT)检查的患者,排除了已知孕前糖尿病的患者。
在符合纳入/排除标准的 2000 名患者中,新诊断妊娠糖尿病的总体患病率为 24.0%(95%CI 22.1-25.9),其中 T2DM 占 2.5%(95%CI 1.9-3.3),GDM 占 21.5%(95%CI 19.7-23.3)。不同种族群体的新诊断妊娠糖尿病患病率相似。T2DM 组年龄较大(平均年龄为 34 ±5.7 岁,31.7±5.7 岁,29.7±5.7 岁,p<0.001),平均 BMI 较高(32.4±6.4kg/m2,31.7±6.2kg/m2,29.7±6.2kg/m2,p<0.01),分别高于 GDM 组和非 DM 组。与 GDM 和非 DM 组相比,T2DM 组子痫前期、早产、剖宫产、巨大儿、LGA 和新生儿 ICU 入院的发生率显著更高。
在卡塔尔居住的不同种族群体中,妊娠期首次诊断的糖尿病患病率相等。新诊断的 T2DM 妊娠结局不良风险更高;强调了正确分类妊娠期新诊断糖尿病病例的重要性。